// App-Quantinova.ai

: Real-Word Clinical Management of Patients Treated with Idelalisib in France: A Study of 529 Cases of Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL)

Researchers

Presenter

  • Anne-Sophie Michallet

Principal Investigators

  • Emmanuel Gyan

  • Pierre Feugier

  • Ana Nunes

  • Tarek Abdelhadi

  • Loic Ysebaert

  • Stphane Leprtre

Medical Centers

  • Service -Hematologie, Centre Leon Berard, Lyon, France

  • Department of Hematology and Cell Therapy, University Hospital of Tours, Tours, France

  • Department of Haematology, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre Les Nancy, France

  • Gilead Sciences, Stockley Parc, United Kingdom

  • Gilead Sciences, Boulogne Billancourt, France

  • Hematology Department, IUCT Oncopole- CHU Purpan, Toulouse, France

  • Inserm U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Univ UNIROUEN,Rouen,France

Locations

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Follicular lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Idelalisib

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved